Why the study?
A thorough analysis of noncardiac determinants of mortality in HF is missing, and evidence conflicts regarding outcomes in patients with HF and no or mild systolic dysfunction.
Population
2791 stable HF patients across HFrEF, HFmrEF, and HFpEF
Comparison
HFpEF vs HFmrEF vs HFrEF
Design
Cohort study
Follow-up
39 months
Authors
Loading...
Noncardiac mortality predominates in HFpEF/HFmrEF; leaves open whether competing-risk interventions improve outcomes.
Noncardiac death is a major determinant of outcome in stable heart failure, exceeding cardiac-related mortality in patients with preserved and midrange ejection fraction.
Vergaro et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: